Abiopharma

News list

Director Nagao Hideki 🟢 acquired 44.5K shares (1 derivative) of MEDICINOVA INC (MNOV) at $1.36 Transaction Date: Jun 23, 2026 | Filing ID: 005111

Full text

News bot June 25, 2026, 8:38 p.m.
🔍 Nagao Hideki (Director)

Company: MEDICINOVA INC (MNOV)

Report Date: 2026-06-23
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 44,500
Detailed Transactions and Holdings:
- Acquired 44,500 shares of Stock Option (Right to Buy) at $1.36 per share (Derivative)
  Date: 2026-06-23 | Code: A | Expires: 2036-06-22 | equity_swap_involved: 0 | shares_owned_after: 44,500.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company.